Becton Dickinson (BDX) and Opentrons Labworks announced a multi-year collaboration. Together, BD and Opentrons will integrate robotic liquid-handling capabilities into BD single-cell multiomics instruments, automating critical experimental steps to accelerate and scale disease research and drug development.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDX:
- Oracle initiated, Ulta Beauty upgraded: Wall Street’s top analyst calls
- Becton Dickinson initiated with a Sector Perform at RBC Capital
- Becton Dickinson teams with Henry Ford Health on robotic pharmaceutical solution
- Becton Dickinson Secures $2.75 Billion Credit Facility
- BDX Advances Safety with New Clinical Study on PosiFlush™ SafeScrub